Overexpression of UCHL1 exacerbates pressure-overload induced cardiac hypertrophy and dysfunction, which can be reversed by systemic administration of the UCHL1 inhibitor LDN-57444 in mice (199). The gene discussed is UCHL1; the disease is cardiac hypertrophy.